ATE112961T1 - Cimetidin enthaltende arzneimittel. - Google Patents
Cimetidin enthaltende arzneimittel.Info
- Publication number
- ATE112961T1 ATE112961T1 AT90313123T AT90313123T ATE112961T1 AT E112961 T1 ATE112961 T1 AT E112961T1 AT 90313123 T AT90313123 T AT 90313123T AT 90313123 T AT90313123 T AT 90313123T AT E112961 T1 ATE112961 T1 AT E112961T1
- Authority
- AT
- Austria
- Prior art keywords
- cimetidine
- medications containing
- containing cimetidine
- release
- medications
- Prior art date
Links
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001380 cimetidine Drugs 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229920003134 Eudragit® polymer Polymers 0.000 abstract 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8916056A FR2655266B1 (fr) | 1989-12-05 | 1989-12-05 | Compositions pharmaceutiques a base de cimetidine. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE112961T1 true ATE112961T1 (de) | 1994-11-15 |
Family
ID=9388166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90313123T ATE112961T1 (de) | 1989-12-05 | 1990-12-04 | Cimetidin enthaltende arzneimittel. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5229134A (de) |
| EP (1) | EP0431877B1 (de) |
| JP (1) | JPH04145016A (de) |
| KR (1) | KR910011257A (de) |
| AT (1) | ATE112961T1 (de) |
| AU (1) | AU629071B2 (de) |
| CA (1) | CA2031066A1 (de) |
| DE (1) | DE69013473T2 (de) |
| DK (1) | DK0431877T3 (de) |
| ES (1) | ES2062417T3 (de) |
| FR (1) | FR2655266B1 (de) |
| IE (1) | IE904364A1 (de) |
| NZ (1) | NZ236326A (de) |
| PT (1) | PT96078A (de) |
| ZA (1) | ZA909685B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA919510B (en) * | 1990-12-05 | 1992-10-28 | Smithkline Beecham Corp | Pharmaceutical compositions |
| US6224911B1 (en) * | 1993-03-16 | 2001-05-01 | Syntex (U.S.A.) Llc | Process for the preparation of enteric coated pharmaceutical dosage forms |
| FR2723586A1 (fr) * | 1994-08-11 | 1996-02-16 | Seth Pawan | Nouvelles compositions contenant de la cimetidine et associations en derivant |
| EP0823255A4 (de) * | 1995-04-03 | 1999-01-27 | Chugai Pharmaceutical Co Ltd | Sucralfat enthaltendes arzneimittel |
| US5789014A (en) * | 1995-12-25 | 1998-08-04 | Shin-Etsu Chemical Co., Ltd. | Method of manufacturing a solid preparation coated with non-solvent coating |
| US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| US5768140A (en) * | 1996-06-21 | 1998-06-16 | Symbol Technologies, Inc. | RF-interrogatable processing system |
| HRP970493A2 (en) | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
| US5916595A (en) * | 1997-12-12 | 1999-06-29 | Andrx Pharmaceutials, Inc. | HMG co-reductase inhibitor |
| WO2000028988A1 (en) * | 1998-11-17 | 2000-05-25 | Nitromed, Inc. | Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
| US6270807B1 (en) | 1999-03-02 | 2001-08-07 | L. Perrigo Company | Taste-masked pharmaceutical composition |
| SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| NZ532096A (en) * | 2001-09-28 | 2006-10-27 | Mcneil Ppc Inc | Dosage forms having an inner core and outer shell with different shapes |
| US6837696B2 (en) * | 2001-09-28 | 2005-01-04 | Mcneil-Ppc, Inc. | Apparatus for manufacturing dosage forms |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US6663888B2 (en) | 2001-12-14 | 2003-12-16 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
| EP1355633B1 (de) | 2001-12-19 | 2005-01-19 | AstraZeneca AB | NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat |
| WO2003053420A1 (en) * | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Multiple-pulse extended release formulations of clindamycin |
| MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
| PE20050335A1 (es) * | 2003-08-07 | 2005-06-01 | Sb Pharmco Inc | Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion |
| EP1753405A4 (de) * | 2004-06-10 | 2008-09-17 | Glatt Air Tech Inc | Pharmazeutische formulierung mit kontrollierter freisetzung |
| US8461187B2 (en) | 2004-06-16 | 2013-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | Multiple PPI dosage form |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US20070298098A1 (en) * | 2005-02-16 | 2007-12-27 | Elan Pharma International Limited | Controlled Release Compositions Comprising Levetiracetam |
| WO2006103702A2 (en) * | 2005-04-01 | 2006-10-05 | Mccullough Ricky W | Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| FR2887455B1 (fr) * | 2005-06-28 | 2007-08-10 | Sanofi Aventis Sa | Formulation a liberation prolongee de principes actifs de medicaments |
| CA2615063A1 (en) * | 2005-07-22 | 2007-02-01 | Myriad Genetics, Inc. | High drug load formulations and dosage forms |
| NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
| WO2007143158A2 (en) * | 2006-06-01 | 2007-12-13 | Schering-Plough Healthcare Products, Inc. | Sustained release pharmaceutical formulation comprising phenylephrine |
| WO2007143163A2 (en) * | 2006-06-01 | 2007-12-13 | Schering Corporation | Pharmaceutical compositions for sustained release of phenyephrine |
| WO2007145191A1 (ja) | 2006-06-13 | 2007-12-21 | Nippon Shinyaku Co., Ltd. | 被覆錠剤 |
| WO2009049160A1 (en) | 2007-10-12 | 2009-04-16 | Takeda Pharmaceuticals North America | Methods of treating gastrointestinal disorders independent of the intake of food |
| JP5524624B2 (ja) * | 2007-11-16 | 2014-06-18 | 旭化成ケミカルズ株式会社 | 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤 |
| CA2738197C (en) | 2008-09-24 | 2016-01-05 | Evonik Operations Gmbh | Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| EP2408437A1 (de) * | 2009-03-18 | 2012-01-25 | Evonik Röhm GmbH | Pharmazeutische zusammensetzung mit kontrollierter freisetzung und widerstandsfestigkeit gegen den einfluss von ethanol mit einer beschichtung aus einem polymergemisch und hilfsstoffen |
| CN102958515A (zh) | 2009-12-02 | 2013-03-06 | 阿普塔利斯制药有限公司 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
| WO2013098842A2 (en) * | 2011-11-03 | 2013-07-04 | Wincoat Colours And Coatings Private Limited | Novel film coating composition |
| CA2936740C (en) | 2014-10-31 | 2017-10-10 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| CN111991364B (zh) * | 2020-09-03 | 2022-07-22 | 四川省百草生物药业有限公司 | 一种盐酸洛美利嗪渗透泵片及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968507A (en) * | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
| US4851228A (en) * | 1984-06-20 | 1989-07-25 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic |
| IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
| US4976949A (en) * | 1985-10-25 | 1990-12-11 | The University Of Michigan | Controlled release dosage form |
| SE461891B (sv) * | 1986-11-19 | 1990-04-09 | Roland Palm | Medel foer utvaertes behandling av husdjur, foerfarande foer framstaellning av naemnda medel samt anvaendning daerav foer behandling av juver och spenar hos kor |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| JP2646251B2 (ja) * | 1987-10-20 | 1997-08-27 | 富士写真フイルム株式会社 | 多層同時塗布方法及び装置 |
| GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
-
1989
- 1989-12-05 FR FR8916056A patent/FR2655266B1/fr not_active Expired - Lifetime
-
1990
- 1990-11-28 CA CA002031066A patent/CA2031066A1/en not_active Abandoned
- 1990-12-03 ZA ZA909685A patent/ZA909685B/xx unknown
- 1990-12-03 AU AU67704/90A patent/AU629071B2/en not_active Ceased
- 1990-12-03 JP JP2400217A patent/JPH04145016A/ja active Pending
- 1990-12-04 DE DE69013473T patent/DE69013473T2/de not_active Expired - Fee Related
- 1990-12-04 DK DK90313123.3T patent/DK0431877T3/da active
- 1990-12-04 EP EP90313123A patent/EP0431877B1/de not_active Expired - Lifetime
- 1990-12-04 ES ES90313123T patent/ES2062417T3/es not_active Expired - Lifetime
- 1990-12-04 IE IE436490A patent/IE904364A1/en unknown
- 1990-12-04 AT AT90313123T patent/ATE112961T1/de not_active IP Right Cessation
- 1990-12-04 PT PT96078A patent/PT96078A/pt not_active Application Discontinuation
- 1990-12-04 NZ NZ236326A patent/NZ236326A/en unknown
- 1990-12-05 KR KR1019900020230A patent/KR910011257A/ko not_active Withdrawn
- 1990-12-05 US US07/622,895 patent/US5229134A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04145016A (ja) | 1992-05-19 |
| FR2655266B1 (fr) | 1992-04-03 |
| KR910011257A (ko) | 1991-08-07 |
| DK0431877T3 (da) | 1995-04-03 |
| EP0431877B1 (de) | 1994-10-19 |
| NZ236326A (en) | 1993-05-26 |
| AU629071B2 (en) | 1992-09-24 |
| ZA909685B (en) | 1992-07-29 |
| IE904364A1 (en) | 1991-06-05 |
| US5229134A (en) | 1993-07-20 |
| PT96078A (pt) | 1991-09-30 |
| DE69013473T2 (de) | 1995-03-16 |
| DE69013473D1 (de) | 1994-11-24 |
| EP0431877A1 (de) | 1991-06-12 |
| ES2062417T3 (es) | 1994-12-16 |
| FR2655266A1 (fr) | 1991-06-07 |
| AU6770490A (en) | 1991-06-27 |
| CA2031066A1 (en) | 1991-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE112961T1 (de) | Cimetidin enthaltende arzneimittel. | |
| DE3650315D1 (de) | Cyancrotonsäureamidverbindung als Arzneimittel mit immunmodulierenden Eigenschaften. | |
| ATE75142T1 (de) | Dhp-manteltablette. | |
| ATE151285T1 (de) | Orale arzneimittel mit kolonspezifischer freisetzung | |
| DE69025208D1 (de) | Arzneimittel mit verzögerter Freigabe | |
| DE69104777D1 (de) | Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen. | |
| DE69427568D1 (de) | Rasch freisetzende Tablettenkerne mit unlöslichen Arzneistoffen und mit einem Retardüberzug | |
| EP0652770A4 (de) | Orale gabe von antigenen. | |
| DE69632533D1 (de) | Intrapulmonare verabreichung vom hematopoietischem medikament | |
| DK343388D0 (da) | 2,2-dimethylchroman-3-ol-derivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne samt disse anvendelse til fremstilling af farmaceutiske midler | |
| BR9610821A (pt) | Derivado de aminoácido uso de um composto e medicamento contendo o mesmo | |
| DE68902300D1 (de) | Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure. | |
| DE68920896D1 (de) | N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung. | |
| DK439589D0 (da) | Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme | |
| ITMI912225A1 (it) | Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10- ilmetil)-l-azabiciclo (2. 2. 2. )ottano e composizioni farmaceutiche che li contengono | |
| NO923808D0 (no) | Substituert sulfonamidderivat og farmasoeytisk formuleringinneholdende det samme | |
| FI950575A7 (fi) | 3- ja 5-substituoidut 1,2,3,4-oksatriatsoli-5-imiiniyhdisteet, niiden valmistusmenetelmä, mainittuja yhdisteitä sisältävä farmaseuttinen valmiste ja mainittujen yhdisteiden käyttö lääkkeiden valmistukseen | |
| FR2702960B1 (fr) | Leurre pour l'administration orale de médicaments vétérinaires. | |
| RU93042104A (ru) | Противокашлевая композиция, содержащая декстрометорфан, способ ее применения | |
| FI935915A7 (fi) | 2-tienyyli-imidatso(2,1-b)bentsotiatsol-3-etikkahappojohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| NL185666C (nl) | Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen. | |
| ITMI911093A0 (it) | Composizione farmaceutica contenente un'associazione di 3,4-di-o isobutirril-epinina ed isosorbide-5- monoidrato | |
| IT8820571A0 (it) | Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica, sua preparazione e relative composizioni farmaceutiche. | |
| FR2655344B1 (fr) | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. | |
| FR2661677B1 (fr) | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |